Vaporox (VHT) is an FDA-cleared wound care solution that uses hydrating vapor and concentrated oxygen to promote rapid healing. Ideal for use in skilled nursing facilities and private practice, to reduce bioburden, stimulate tissue growth, and help improve patient outcomes.

VHT is a non-thermal treatment consisting of vapor/mist and concentrated oxygen. VHT’s vapor/mist is generated using non-contact, low-frequency, ultrasonic crystals. It has been clinically validated as a safe and effective adjunctive treatment for healing nine types of skin wounds.

Vaporox provides a hassle-free approach to chronic wound healing. Our treatment fits seamlessly into your facility with minimal setup, no additional infrastructure, and a comfortable experience for patients.

Mar 27, 2023 · Vaporox is a Denver-based medical device company commercializing Vaporous Hyperoxia Therapy (VHT), a patented and FDA 510 (k)-cleared technology that has been clinically validated as a safe and effective treatment for healing wounds. Vaporox’s initial focus is on diabetic foot ulcers (DFUs).

Mar 27, 2023 · Vaporox is a Denver-based medical device company commercializing Vaporous Hyperoxia Therapy (VHT), a patented and FDA 510 (k)-cleared technology that has been clinically validated as...

May 30, 2024 · Vaporox is not just a healing agent; it’s a protective measure against one of the biggest worries in wound care. By preventing infection, Vaporox not only speeds up wound healing, but it also ensures that the healing process goes smoothly and without any hiccups.

Vaporous Hyperoxia Therapy or VHT® is a Low-Frequency, Non-Contact, Non-Thermal Ultrasonic Mist Therapy with the application of concentrated topical oxygen. It is an FDA-cleared technology, ensuring its safety and effectiveness as an adjunctive treatment method.

Mar 28, 2023 · The US Food and Drug Administration (FDA) has granted clearance for Vaporox’s next-generation VHT-200 medical device system to heal chronic wounds. The patented, FDA 510(k)-cleared breakthrough technology Vaporous Hyperoxia Therapy (VHT) is a low-frequency, non-contact, non-thermal ultrasound treatment.

VHT (Vaporox) is a patented, FDA 510 (k) Class II (#K212121)–cleared technology that has been clinically validated as a safe and effective adjunct treatment for healing skin wounds, including DFUs, venous leg ulcers, postoperative wounds, decubitus wounds, amputation sites, skin grafts, burns, frostbite, and gangrene.

Reiterating the core benefits of Vaporox, clinicians frequently emphasize that Vaporox is an innovative wound healing technology that utilizes vaporized hydrogen peroxide to create a sterile environment conducive to healing.